These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 32466419)
1. Liquid Biopsy Serial Monitoring of Treatment Responses and Relapse in Advanced Esophageal Squamous Cell Carcinoma. Ko JMY; Ng HY; Lam KO; Chiu KWH; Kwong DLW; Lo AWI; Wong JC; Lin RCW; Fong HCH; Li JYK; Dai W; Law S; Lung ML Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32466419 [TBL] [Abstract][Full Text] [Related]
2. Circulating Tumor Cell Enumeration for Serial Monitoring of Treatment Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma. Ko JMY; Lam KO; Kwong DLW; Wong IY; Chan FS; Wong CL; Chan KK; Law TT; Chiu KWH; Lam CCS; Wong JC; Fong HCH; Choy FSF; Lo A; Law S; Lung ML Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765790 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma. Qiao Y; Li J; Shi C; Wang W; Qu X; Xiong M; Sun Y; Li D; Zhao X; Zhang D Onco Targets Ther; 2017; 10():1363-1373. PubMed ID: 28424552 [TBL] [Abstract][Full Text] [Related]
4. Baseline and Kinetic Circulating Tumor Cell Counts Are Prognostic Factors in a Prospective Study of Metastatic Colorectal Cancer. Silva VSE; Abdallah EA; Brito ABC; Braun AC; Tariki MS; de Mello CAL; Calsavara VF; Riechelmann R; Chinen LTD Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33809053 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of carcinoembryonic antigen-, cytokeratin 19-, or survivin-positive circulating tumor cells in the peripheral blood of esophageal squamous cell carcinoma patients treated with radiotherapy. Yin XD; Yuan X; Xue JJ; Wang R; Zhang ZR; Tong JD Dis Esophagus; 2012; 25(8):750-6. PubMed ID: 22394149 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial. Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204 [TBL] [Abstract][Full Text] [Related]
7. Post-radiation circulating tumor DNA as a prognostic factor in locally advanced esophageal squamous cell carcinoma. Jia R; Zhao CH; Li PS; Liu RR; Zhang Y; Chen HE; Chang LP; Gong YH; Guan YF; Yi X; Xu JM Oncol Lett; 2021 Jan; 21(1):68. PubMed ID: 33365079 [TBL] [Abstract][Full Text] [Related]
8. Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma. Hsieh CC; Hsu HS; Chang SC; Chen YJ Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999323 [TBL] [Abstract][Full Text] [Related]
9. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy. Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516 [TBL] [Abstract][Full Text] [Related]
10. Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy. Chen W; Li Y; Yuan D; Peng Y; Qin J Thorac Cancer; 2018 Aug; 9(8):956-966. PubMed ID: 29893036 [TBL] [Abstract][Full Text] [Related]
11. Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients. Thalgott M; Rack B; Eiber M; Souvatzoglou M; Heck MM; Kronester C; Andergassen U; Kehl V; Krause BJ; Gschwend JE; Retz M; Nawroth R BMC Cancer; 2015 Jun; 15():458. PubMed ID: 26051431 [TBL] [Abstract][Full Text] [Related]
12. Monitoring disease progression and treatment efficacy with circulating tumor cells in esophageal squamous cell carcinoma: A case report. Qiao YY; Lin KX; Zhang Z; Zhang DJ; Shi CH; Xiong M; Qu XH; Zhao XH World J Gastroenterol; 2015 Jul; 21(25):7921-8. PubMed ID: 26167094 [TBL] [Abstract][Full Text] [Related]
13. Preoperative chemotherapy compared with postoperative adjuvant chemotherapy for squamous cell carcinoma of the thoracic oesophagus with the detection of circulating tumour cells randomized controlled trial. Zhao Y; Han L; Zhang W; Shan L; Wang Y; Song P; Peng C; Zhao X Int J Surg; 2020 Jan; 73():1-8. PubMed ID: 31756547 [TBL] [Abstract][Full Text] [Related]
14. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence. Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701 [TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Monitoring Circulating Free DNA and Plasma Heat Shock Protein 90alpha in Patients with Esophageal Squamous Cell Carcinoma. Zhao Q; Miao C; Lu Q; Wu W; He Y; Wu S; Liu H; Lian C Cancer Manag Res; 2021; 13():2223-2234. PubMed ID: 33707971 [TBL] [Abstract][Full Text] [Related]
16. Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts. Lorente D; Olmos D; Mateo J; Dolling D; Bianchini D; Seed G; Flohr P; Crespo M; Figueiredo I; Miranda S; Scher HI; Terstappen LWMM; de Bono JS Ann Oncol; 2018 Jul; 29(7):1554-1560. PubMed ID: 29741566 [TBL] [Abstract][Full Text] [Related]
17. Detection of Circulating Tumor Cells by Fluorescent Immunohistochemistry in Patients with Esophageal Squamous Cell Carcinoma: Potential Clinical Applications. Li SP; Guan QL; Zhao D; Pei GJ; Su HX; Du LN; He JX; Liu ZC Med Sci Monit; 2016 May; 22():1654-62. PubMed ID: 27184872 [TBL] [Abstract][Full Text] [Related]
18. Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells. Souza E Silva V; Chinen LT; Abdallah EA; Damascena A; Paludo J; Chojniak R; Dettino AL; de Mello CA; Alves VS; Fanelli MF Onco Targets Ther; 2016; 9():7503-7513. PubMed ID: 28008271 [TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443 [TBL] [Abstract][Full Text] [Related]
20. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma. Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]